rewirebio.iobenchmarks
Evaluation

End Motifs on pe validation (Zeng et al. 2026)

Published comparison; transcribed, not reproduced.

Evaluation results

1 evaluation · 2 results. Different protocols are not a single leaderboard.

Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy · Dataset: Zeng et al. 2026 independent paired-end validation dataset

Sorted by AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationAUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models)Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models)
Zeng et al. 2026 classifier: End MotifsEvaluation0.1880.0222
All 2 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Zeng et al. 2026 classifier: End MotifsProtocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy
Dataset: Zeng et al. 2026 independent paired-end validation dataset
0.188 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0590546576842708. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

End Motifs on pe validation (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-validation

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 3 'End Motifs', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: End MotifsProtocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy
Dataset: Zeng et al. 2026 independent paired-end validation dataset
0.0222 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.0104756560175785 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

End Motifs on pe validation (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-validation

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 11 'End Motifs', column B 'mean_sens99'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Evaluation procedure

Zeng et al. 2026 independent PE validation dataset: cancer vs healthy

Configuration
Zeng et al. 2026 classifier: End Motifs
Protocol
Zeng et al. 2026 independent PE validation dataset: cancer vs healthy
Dataset
Zeng et al. 2026 independent paired-end validation dataset
origin
Author-reported evaluation
configuration
Primary source as retrieved 2026-10-11
protocol id
ctdnalit-20261011-zeng2026-protocol-pe-validation
dataset version
Zeng et al. 2026 PE validation dataset
split
Independent validation of the 10 fold models
population
Independent PE validation samples (95 or 140; see dataset)
inputs
PCs of 5' 4-mer end-motif frequencies
adaptation
Trained on the primary dataset of the same sequencing mode
metric implementation
Not reported
aggregation
Mean over 10 cross-validation fold models
budget
Not reported

Metadata review: source checked. Unreported conditions prevent automatic comparisons.

Reproduction

Split
Independent validation of the 10 fold models
Adaptation
Trained on the primary dataset of the same sequencing mode
Scoring implementation
Not reported

No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.

Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

38 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Comparison: adaptation
Trained on the primary dataset of the same sequencing mode
Context-only references
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

Original source ↗

Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
Retrieved: 2026-10-11T21:40:43Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.adaptation

Source artifact SHA-256: 72e823206c332b5e7649e813e130e9d5122d202bac56cbcc55358b81e761e323

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: adaptation
Trained on the primary dataset of the same sequencing mode
Context-only references
Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries)

Original source ↗

Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.adaptation

Source artifact SHA-256: fae751686bbe1a15c5e1e2312b8679afd235a97b305b56f925744788ab0163b4

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: aggregation
Mean over 10 cross-validation fold models
Context-only references
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

Original source ↗

Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
Retrieved: 2026-10-11T21:40:43Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.aggregation

Source artifact SHA-256: 72e823206c332b5e7649e813e130e9d5122d202bac56cbcc55358b81e761e323

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: aggregation
Mean over 10 cross-validation fold models
Context-only references
Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries)

Original source ↗

Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.aggregation

Source artifact SHA-256: fae751686bbe1a15c5e1e2312b8679afd235a97b305b56f925744788ab0163b4

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: budget
Not reported
Context-only references
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

Original source ↗

Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
Retrieved: 2026-10-11T21:40:43Z

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.budget

Source artifact SHA-256: 72e823206c332b5e7649e813e130e9d5122d202bac56cbcc55358b81e761e323

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: budget
Not reported
Context-only references
Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries)

Original source ↗

Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.budget

Source artifact SHA-256: fae751686bbe1a15c5e1e2312b8679afd235a97b305b56f925744788ab0163b4

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: dataset version
Zeng et al. 2026 PE validation dataset
Context-only references
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

Original source ↗

Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
Retrieved: 2026-10-11T21:40:43Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.dataset_version

Source artifact SHA-256: 72e823206c332b5e7649e813e130e9d5122d202bac56cbcc55358b81e761e323

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: dataset version
Zeng et al. 2026 PE validation dataset
Context-only references
Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries)

Original source ↗

Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.dataset_version

Source artifact SHA-256: fae751686bbe1a15c5e1e2312b8679afd235a97b305b56f925744788ab0163b4

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: inputs
PCs of 5' 4-mer end-motif frequencies
Context-only references
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

Original source ↗

Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
Retrieved: 2026-10-11T21:40:43Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.inputs

Source artifact SHA-256: 72e823206c332b5e7649e813e130e9d5122d202bac56cbcc55358b81e761e323

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: inputs
PCs of 5' 4-mer end-motif frequencies
Context-only references
Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries)

Original source ↗

Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.inputs

Source artifact SHA-256: fae751686bbe1a15c5e1e2312b8679afd235a97b305b56f925744788ab0163b4

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: ctdnalit-20261011-zeng2026-eval-pe-validation-end-motifs

areas
dna-genomes
contexts
clinical_research
origin
author_reported
protocol
ctdnalit-20261011-zeng2026-protocol-pe-validation
version
Primary source as retrieved 2026-10-11
comparison
protocol id: ctdnalit-20261011-zeng2026-protocol-pe-validation; dataset version: Zeng et al. 2026 PE validation dataset; split: Independent validation of the 10 fold models; population: Independent PE validation samples (95 or 140; see dataset); inputs: PCs of 5' 4-mer end-motif frequencies; adaptation: Trained on the primary dataset of the same sequencing mode; metric implementation: Not reported; aggregation: Mean over 10 cross-validation fold models; budget: Not reported
source locator
Source Data Fig. 4, sheets Fig.4c and Fig.4d, row 'End Motifs'
limitations
Includes 5' end motifs, whose baseline differs in the HCC-study healthy controls (Results P32).
missing metadata
comparison.budget: reason: inapplicable; comparison.metric implementation: reason: unreported; note: ROC and threshold code not described
Related records

Suggest a correction